ArticleInternational journal of nursing studies advances2025
Delirium prevalence and management in general wards, emergency departments, rehabilitation centres and nursing homes in Germany, Austria and Switzerland (DACH countries): A secondary analysis of a worldwide point prevalence study.
Article in International journal of nursing studies advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Clinical characteristics and risk factors associated with consultation-confirmed delirium in hospitalized patients.PCN reports : psychiatry and clinical neurosciences · 2026Article
- Relevance and Feasibility of a "Geriatric Delirium Pass" for Older Patients with Elective Surgeries: Findings from a Multi-Methods Study.Geriatrics (Basel, Switzerland) · 2026Article
- Implementation context, mechanisms and outcomes of a transitional care intervention to prevent delirium: a mixed-methods process evaluation from the TRADE study.BMC geriatrics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Delirium is a common neuropsychiatric syndrome associated with an increased risk of mortality and length of stay. Current delirium prevalence, assessments and management practices of delirium in DACH countries are unknown. Objective: To examine the delirium point prevalence, assessment, management practices in general wards, emergency departments, rehabilitation centres and nursing homes in DACH countries. Design: Secondary data analysis from a prospective, cross-sectional, worldwide one-day point delirium prevalence study (registered in the German Registry for Clinical Trials, DRKS00030002). Settings: General hospital wards, emergency departments, rehabilitation centres and nursing homes excluding operating rooms, ambulatory, high acuity, intermediate care and intensive care units. Participants: In total, 172 wards (majority were general wards; 91.3 %, Methods: Descriptive analysis of a 39-questions online survey with aggregated routine patient and facility data completed by healthcare professionals, administrators, and researchers on World Delirium Awareness Day, March 15th, 2023. Data on delirium prevalence were collected at 8:00 A.M. and P.M. (± 4 h). Use of delirium assessments, delirium awareness structures, presence of care protocols, and barriers to delirium management structures were reported. Results: Overall delirium prevalence was 7.1 % ( Conclusions: Delirium is a frequent complication in patients in DACH countries. More than three quarter of participating wards reported a delirium management protocol suggesting awareness of published guidelines and best practice recommendations. Improved staffing, education on delirium assessment, and interprofessional communication could be helpful to improve the usage of valid delirium assessments and addressing barriers to delirium management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.